TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD
暂无分享,去创建一个
T. Larcher | I. Anegon | B. Fraysse | A. Lafoux | C. Huchet | A. Bourdon | V. François | C. Gazaille | M. Ledevin | O. Adjali | C. Le Guiner | G. Toumaniantz | A. Creisméas | Marc-Antoine Lallemand | M. Allais | Caroline Le Guiner